Briefs: Krsnaa Diagnostics and Anuh Pharma
News

Briefs: Krsnaa Diagnostics and Anuh Pharma

Krsnaa Diagnostics receives LoI from RINPAS for radiology services

  • By IPP Bureau | September 27, 2024

Krsnaa Diagnostics receives LoI from RINPAS for radiology services

The Ranchi Institute of Neuro-Psychiatry & Allied Services (RINPAS) has awarded a letter of Intent (LoI) to Krsnaa Diagnostics for supply, install, commission, operate and maintain the Radiology Center (CT & MRI) and Pathology Laboratory Services on Public Private Partnership basis at Ranchi Institute of NeuroPsychiatry & Allied Sciences, Government of Jharkhand, India.

Anuh Pharma received EDQM approval for CEP of Allopurinol API

Anuh Pharma Limited has received approval from EDQM for CEP of Allopurinol API which is used to treat Gout and High Uric Acid Levels.

Upcoming E-conference

Other Related stories

Startup

Digitization